| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |